Paul-Emmanuel Larchanché

Statistics

Publications

Citations

137

H-Index

Active since

2014

Affiliations

Centre de Recherche Jean Pierre Aubert(Current)

Université de Lille

Inserm

Centre Hospitalier Universitaire de Lille

Lille Inflammation Research International Center

Paul-Emmanuel Larchanché is an author at Centre de Recherche Jean Pierre Aubert specializing in enzyme inhibition, medicinal chemistry, and drug discovery.

Publications per year

2014–2019

Publications

New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease

Nicolas Sergeant, Valérie Vingtdeux, Sabiha Eddarkaoui et al. · Neurobiology of Disease · 2019 · 33 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Chloroquine and Chloroquinoline Derivatives as Models for the Design of Modulators of Amyloid Peptide Precursor Metabolism

Patricia Melnyk, Valérie Vingtdeux, Stéphane Burlet et al. · ACS Chemical Neuroscience · 2015 · 32 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Synthesis and pharmacological evaluation of benzamide derivatives as potent and selective sigma-1 protein ligands

Marion Donnier‐Maréchal, Pascal Carato, Paul-Emmanuel Larchanché et al. · European Journal of Medicinal Chemistry · 2017 · 21 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Carboline- and phenothiazine-derivated heterocycles as potent SIGMA-1 protein ligands

Marion Donnier‐Maréchal, Paul-Emmanuel Larchanché, Delphine Le Broc et al. · European Journal of Medicinal Chemistry · 2014 · 19 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +12

New phenylaniline derivatives as modulators of amyloid protein precursor metabolism

Marion Gay, Pascal Carato, Mathilde Coevoet et al. · Bioorganic & Medicinal Chemistry · 2018 · 11 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +14

1–5 of 7